This announcement is a separate document:
雲頂新耀-B：(1)建議重選董事；(2)建議授出購回股份及發行股份的一般授權；(3)建議重新委任退任核數師；(4)建議授出2022年購股權；(5)建議授出2022年股份獎勵；(6)建議授出2022年表現目標獎勵；(7)建議授出2023年購股權；(8)建議授出2023年股份獎勵；(9)建議授出2023年表現目標獎勵；(10)有關授出購股權及授出獎勵的補充資料；及(11)股東週年大會通告
EVEREST MED-B: (1) PROPOSED RE-ELECTION OF DIRECTORS (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES (3) PROPOSED RE-APPOINTMENT OF RETIRING AUDITOR (4) 2022 PROPOSED OPTION GRANT (5) 2022 PROPOSED AWARD GRANT (6) 2022 PR
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated